Real-world adoption of bevacizumab-bvzr biosimilar was retrospectively assessed, revealing switching between biosimilars and the reference product and utilization in extrapolated indications and combination regimens.
Martine C. Maculaitis, PhD
Advertisement
Articles by Martine C. Maculaitis, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Peptide Regulation Debate Intensifies After FDA Advisory Panel's Controversial Vote
2
Health System Pharmacies Keep Patients on GLP-1 Therapy
3
NCCN Journal Publishes Guidelines Update in Mantle Cell Lymphoma
4
Tavapadon for Parkinson Disease Approved by FDA
5